Results 91 to 100 of about 4,776,365 (127)

SARS-CoV-2 crossreactive B-cells outnumber seasonal coronavirus spike-specific clones at the end of the COVID-19 pandemic. [PDF]

Npj Viruses
Gonzalez-Lopez C, Aguilar-Bretones M, Reinders J, Zhang J, van den Doel P, Bekki B, van Gorp EC, van der Kuy PHM, Haagmans BL, GeurtsVanKessel CH, Koopmans MPG, de Vries RD, van Gils MJ, van Nierop GP.   +13 more
europepmc   +2 more sources

Pathological characteristics of SARS-CoV-2 variants and immune responses induced in a COVID-19 macaque model. [PDF]

Commun Biol
Urano E, Okamura T, Higuchi M, Furukawa M, Ueda K, Nagata S, Kamada H, Yasutomi Y.   +7 more
europepmc   +1 more source

Use of immunology in news and YouTube videos in the context of COVID-19: politicisation and information bubbles. [PDF]

Front Public Health
George RS, Goodey H, Russo MA, Tula R, Ghezzi P.   +4 more
europepmc   +1 more source

Comparison of the protective effect of human respiratory syncytial virus Pre-F protein combined with different adjuvants in BALB/c mice. [PDF]

Front Immunol
Chu M, Du L, Hu H, Cao L, Zhang L, Mao N, Zhu Z, Zhang Y, Li H.   +8 more
europepmc   +1 more source

A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults. [PDF]

Vaccines (Basel)
D'Onofrio V, Jacobs B, Alhatemi A, De Gussem S, Verstraete M, Porrez S, Willems A, De Boever F, Waerlop G, Leroux-Roels G, Michels E, Vanni F, Manenti A, Platenburg PP, Hilgers L, Leroux-Roels I.   +15 more
europepmc   +1 more source

A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression. [PDF]

Virol Sin
Yu W, Chen X, Chen Q, Chen P, Liu N, Li Y, Tan X, Zhang Q, Rao Y, Guo M, Huang Z, Wang X, Zhang Z, Xiang W, Zhang Y, Liu Q, Yin H, Zhou L, Chen Y, Lan K.   +19 more
europepmc   +1 more source

Estimating Zika Virus Seroprevalence in a Dengue Virus-Endemic Population: The Use of Blood Donors and Multiplex Serology to Monitor Arbovirus Outbreaks in the Dutch Caribbean. [PDF]

J Infect Dis
Kasbergen LMR, Sikkema RS, Chandler F, van Beek JHG, Halabi Y, Lourents N, Maduro EG, Gerstenbluth I, Duits A, Koopmans MPG.   +9 more
europepmc   +1 more source

Screening for next generation vaccines in human immune organoids. [PDF]

Immunohorizons
Chen GB, Smith A, Lee J, Kang P, Siva O, Davis MM.   +5 more
europepmc   +1 more source

Artificial "zombie" cells: An emerging platform for targeted drug delivery and disease treatment. [PDF]

Acta Pharm Sin B
Sun Y, Feng J, Xing Y, Sun P, Liao M, Tan X, Wang Y.   +6 more
europepmc   +1 more source

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants. [PDF]

Front Immunol
Chen L, He Y, Liu H, Shang Y, Guo G.
europepmc   +1 more source